Adaptation and Validation of the Israeli Version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL).

Aharon Kessel(Technion – Israel Institute of Technology), Elias Toubi(Bnai Zion Medical Center), Ilaria Baiardini(Ospedale Policlinico San Martino), Nili Stein(Carmel Medical Center), Schichter-Konfino(Bnai Zion Medical Center), Teplitski(Rabin Medical Center), Zahava Vadasz(Bnai Zion Medical Center), Yael Graif(Rabin Medical Center), Marcus Maurer(Humboldt-Universität zu Berlin), Meital Almog(Bnai Zion Medical Center)
PubMed
August 1, 2016
Cited by 14

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The <scp>EAACI</scp>/<scp>GA</scp><sup>2</sup><scp>LEN</scp>/<scp>EDF</scp>/<scp>WAO</scp> Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Allergy|2014|1.2k
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
|Dermatology Review|2015|428
Epidemiology of urticaria: a representative cross-sectional population survey
|Clinical and Experimental Dermatology|2010|363